Cai, E. Y., Zhang, L., Robinson, W., Avins, D., Kouchkovsky, I. D., Kwon, D. H., Desai, A., Fitzgerald, K. N., Bose, R., Chou, J., Friedlander, T. W., Koshkin, V. S., Zhu, X., Younger, N. S., Aslam, M., Gonzales, G., Small, E. J., Liu, B., Flavell, R. R., Aggarwal, R. R. (2026). A phase 1b/2 study of FOR46 in combination with enzalutamide (enza) in patients with metastatic castration resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.149